Senior insider sale
Chief Operating Officer at GYRE THERAPEUTICS, INC. — senior position signals high conviction
$4.57M
548K shares
What this filing means
YE WEIGUO plans to sell 548K shares of GYRE THERAPEUTICS, INC. valued at approximately $4.57M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/13/2025ACC: 0001985496-25-000003
Officer· Chief Operating Officer
Since Oct 2023
548K
Shares to sell
$4.57M
Approx. market value
548K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock Option Exercise
Cash
11/15/2025
348KStock Option Exercise
Cash
3/24/2025
200KTotal acquired548K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2025 | Stock Option Exercise Cash | 348K | — |
3/24/2025 | Stock Option Exercise Cash | 200K | — |
| Total | 548K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
548K
Market value
$4.57M
11/15/2025
Total
Units
548K
Value
$4.57M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/15/2025 | 548K | $4.57M | NASDAQ | Planned |
| Total | 548K | $4.57M | ||